Investor information
Regulatory and investor information published in accordance with rule 4.14 of the Aquis Growth Market Rulebook.
Trading in the Company’s ordinary shares is temporarily suspended. The suspension took effect from 08:00 on 1 October 2026, pursuant to rule 5.1 of the Aquis Growth Market Rulebook, following a delay to the completion and publication of the Company’s audited accounts for the year ended 29 March 2026. See the announcement of 1 October 2026.
Corporate information
Incorporation, registered office, constitution and advisers.
Board & governance
Directors, their biographies, and the Company’s corporate governance statement.
Share capital
Shares in issue, significant shareholders, convertible instruments and dilution.
Announcements
Regulatory announcements made by the Company.
Documents
Annual reports, interim results, the admission document and shareholder circulars.
About this website
This website is maintained by TSP Advanced Technologies Plc for the purpose of making available to investors the information required by rule 4.14 of the Aquis Growth Market Rulebook. All information is made publicly available free of charge and is kept up to date.
The Company
TSP Advanced Technologies Plc, formerly TruSpine Technologies Plc, develops disruptive technologies for the spinal stabilisation market. Its products are the Cervi-LOK system for the cervical and upper thoracic spine, the Faci-LOK system for the lumbar and lower thoracic spine, and the GRASP Laminoplasty system for decompression of the spinal cord.
This page was last updated on 1 October 2026.